Бедретдинова Д.А.

The approach to the pathogenesis, diagnosis and treatment of diseases of the pelvic organs has changed, becoming more complex. It is connected with the phenomenon of so-called cross-sensitization, and the fact that in the pathogenesis of chronic pelvic pain syndrome is dominated by myofascial (spastic) symptoms of pelvic floor and pudendal nerve neuropathy. This leads to a change in terminology, which creates a certain amount of confusion.

Prostate cancer (PCa) – one of the most common diseases among the male population of the world, providing a major impact on world health and economy. It is believed that the disease within the first 15 years after detection is relatively indolent, and a significant increase in mortality rates is observed after 15 years. High popularity of screening led to overdiagnosis, ie, the detection of clinically insignificant prostate cancer.

Cernilton® Efficiency and Safety in Treatment of Patients with Chronic Abacterial Prostatitis and BPH Evaluation Recent A.V. Sivkov, D.A. Bedretdinova Cernilton® is a medication which active components are microbiologically fermented pollen extract of various plants. Medicine has antiedemic and anti-inflammatory activity, capable to inhibit 5-а reductase thus slowing down prostate cells proliferation. Also improves voiding by а-1 receptors blocking and direct relaxation activity on urethral smooth muscles.

Medical education is one the most important factors of providing high professional level of healthcare specialists. The basement of medical professional formation is postgraduate education, which at present day for a number of reasons do not manage the task of training of high qualified medical professionals. Existing postgraduate educational system in Russia wasn't reformed for more than 40 years!

A study on the effectiveness and safety of two dosing regimens of the drug Cernilton® in patients with chronic nonbacterial prostatitis was performed. The patients were randomized into two groups.